Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence

Experimental Gerontology

Volumn 31, Issue 1-2, 1996, Pages 175-193

  West, Michael D ^a   Shay, Jerry W ^b   Wright, Woodring E ^b   Linskens, Maarten H K ^a  

^a GERON CORPORATION   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

cell senescence; plasminogen activator; plasminogen activator inhibitor

Indexed keywords

GENE PRODUCT; MESSENGER RNA; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; FETUS; FIBROBLAST; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NEWBORN; NORTHERN BLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SENESCENCE;

EID: 0029962187     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/0531-5565(95)02013-6     Document Type: Article

References (50)

1. ALESSI, M., JUHAN-VAGUE, I., KOOISTRA, T., DECLERCK, P., and COLLEN, D. Insulin stimulates the synthesis of plasminogen activator inhibitor-1 by the human hepatocellular cell line HepG2. Thromb. Haemost. 60: 491-494, 1988.
2. AUWERX, J., BOUILLON, R., COLLEN, D., and GEBEORS, J. Tissue type plasminogen activator and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 8: 68-72, 1988.
3. AZNAR, J., ESTELLES, A., TORMO, G., SAPENA, P., TORMO, V., BLANCH, S., and ESPANA, F. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease. Br. Heart J. 59: 535-541, 1988.
4. BOOTHMAN, D.A., WANG, M., and LEE, S.W. Induction of tissue-type plasminogen activator by ionizing radiation in human malignant melanoma cells. Cancer Res. 51: 5587-5595, 1991.
5. BOOTHMAN, D.A., LEE, I.W., and SAHIJDAK, W.M. Isolation of an X-ray-responsive element in the promoter region of tissue-type plasminogen activator: Potential uses of X-ray-responsive elements for gene therapy. Rad. Res. 138: S68-S71, 1994.
6. CASTELLINO, F.J. Biochemistry of human plasminogen. Semin. Thromb. Haemost. 10: 18-23, 1984.
7. CHMIELEWSKA, J., RANBY, M., and WIMAN, B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb. Res. 31: 427-436, 1983.
8. DANO, K., ANDREASEN, P.A., GRONDAHL-HANSEN, J., KRISTENSEN, P., NIELSEN, L.S., and SKRIVER, L. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44: 139-266, 1985.
9. DE PETRO, G., COPETA, A., and BARLATI, S. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp. Cell Res. 213: 286-294.
10. DOGGETT, D.L., ROTENBERG, M.D., PIGNOLO, R.J., PHILLIPS, P.D., and CRISTOFALO, V.J. Differential gene expression between young and senescent quiescent WI-38 cells. Mech. Aging Dev. 65: 239-255, 1992.
11. DUNBAR, B.S. Two-Dimensional Electrophoresis and Immunological Techniques. Plenum Press, N.Y. 1987.
12. EMEIS, J., and KOOISTRA, T. Interleukin-1 and lipopolysaccharide induce a fast acting inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J. Exp. Med. 163: 1260-1266, 1986.
13. ERICKSON, L.A., FICI, G.J., LUND, J.E., BOYLE, T.P., POLITES, G., and MAROTTI, K.R. Development of venous occlusions in mice transgenic for plasminogen activator inhibitor-1. Nature 346: 74-76, 1990.
14. GARFINKEL, S., BROWN, S., WESSENDORF, J.H.M., and MACIAG, T. Post-transcriptional regulation of interleukin 1α in various strains of young and senescent human umbilical vein endothelial cells. Proc. Natl. Acad. Sci. USA., 91: 1559-1563, 1994.
15. GOLDSTEIN, S. Replicative senescence: The human fibroblast comes of age. Science 249: 1129-1133, 1990.
16. GOLDSTEIN, S., MOERMAN, E.J., FUJII, SA., and SOBEL, B.E. Overexpression of plasminogen activator inhibitor type-1 in senescent fibroblasts from normal subjects and those with Werner syndrome. J. Cell. Physiol. 161: 571-579, 1994.
17. GRANELLI-PIPERNO, A., and REICH, E. A study of proteases and protease-inhibitor complexes in biological fluids. J. Exp. Med. 148: 223-234, 1978.
18. HAMSTEN, A., WILMAN, B., DE FAIRE, U., and BLOMBACK, M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator inhibitor in young survivors of myocardial infarction. N. Engl. J. Med. 313: 1557-1563, 1985.
19. HAMSTEN, A., BLOMBACK, M., WIMAN, B., SVENSSON, J., SZAMOSI, A., DE FAIRE, U., and METTINGER, L. Haemostatic function in myocardial infarction. Br. Heart J. 55: 58-66, 1986.
20. HAMSTEN, A., DE FAIRE, U., WALLDIUS, G., DAHLEN, G., SZAMOSI, A., LANDOU, C., BLOMBACK, M., and WIMAN, B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 2: 3-9, 1987.
21. HARLEY, C.B. Telomere loss: mitotic clock or genetic time bomb? Mutation Research. 256: 271-282, 1991.
22. HEDMAN, K., HURKINEN, M., ALITALO, K., VAHERI, A., JOHANSSON, S., and HOOK, M. Isolation of the pericellular matrix of human fibroblast cultures. J. Cell Biol. 81: 83-91, 1979.
23. HUANG, J.S., OLSEN, T.J., and HUANG, S.S. The role of growth factors in tissue repair I: Platelet-derived growth factor. In: The Molecular and Cellular Biology of Wound Repair, Clark, R.A.F. and Henson, P.M. (Editors), pp. 243-251, Plenum Press, NY, 1988.
24. JOHNSON, O., MELLBRING, G., and NILSSON, T. Defective fibrinolysis in survivors of myocardial infarction. Int. J. Cardiol. 6: 380-382, 1984.
25. KUMAR, S., VINCI, J.M., MILLIS, A.J.T., and BAGLIONI, C. Expression of interleukin-1α and β in early passage fibroblasts from aging individuals. Exp. Gerontol. 28: 505-513, 1993.
26. LAEMMLI, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
27. LOSKUTOFF, D.J. Type 1 plasminogen activator inhibitor and its potential influence on thrombolytic therapy. Sem. Thromb. Haemostatis. 14: 100-109, 1988.
28. MARTIN, G.M. Proliferative homeostasis and its age-related aberrations. Mech. Ageing Dev. 9: 5-6, 1979.
29. MIGNATTI, P., WELGUS, H.G., and RIFKIN, D.B. Role of degradative enzymes in wound healing. In: The Molecular and Cellular Biology of Wound Repair, Clark, R.A.F. and Henson, P.M. (Editors), pp. 497-523, Plenum Press, NY, 1988.
30. MURANO, S., THWEATT, R., SHMOOKLER REIS, R.J., JONES, R.A., MOERMAN, E.J., and GOLDSTEIN, S. Diverse gene sequences are overexpressed in Werner syndrome fibroblasts undergoing premature replicative senescence. Mol. Cell. Biol. 11: 3905-3914, 1991.
31. NY, T., SAWDEY, M., LAWRENCE, D., MILLAN, J., and LOSKUTOFF, D. Cloning and sequencing of a cDNA coding for the human B-migrating endothelial cell type plasminogen activator inhibitor. Proc. Natl. Acad. Sci. USA. 83: 6776-6780, 1986.
32. PARAMO, J.A., COLUCCI, M., COLLEN, D., and VAN DE WERF, F. Plasminogen activator inhibitor in the blood of patients with coronary artery disease. Br. Med. J. 291: 573-574, 1985.
33. RANBY, M., BERGSDORF, N., NILSSON, T., MELLBRING, G., WINBLAD, B., and BUCHT, G. Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay. Clin. Chem. 32: 2160-2165, 1986.
34. RICCIO, A., LUND, L.R., SARTORIO, R., LANIA, A., ANDREASEN, P.A., DANO, K., and BLASI, F. The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene. Nucleic Acids Res. 16: 2805-2824, 1988.
35. RUBELJ, I., PEREIRA-SMITH O. SV-40-transformed human cells in crisis exhibit changes that occur in normal cellular senescence. Exp. Cell Res. 211: 82-89, 1994.
36. SAKSELA, O. Radial caseinolysis in agarose: A simple method for detection of plasminogen activator in the presence of inhibitory substances and serum. Anal. Biochem. 111: 276-282, 1981.
37. SAKSELA, O. Plasminogen activation and regulation of pericellular proteolysis. Biochim. Biophys. Acta. 823: 35-65, 1985.
38. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. Molecular Cloning; A Laboratory Manual, Second Ed., Vol. 1, pp. 7.43-7.52 Cold Spring Harbor Press, Cold Spring Harbor, NY, 1989.
39. SAWAYA, R., RAYFORD, A., KONO, S., ANG, K.K., FENG, Y., STEPHENS, L.C., and RAO, J.S. Elevated levels of plasminogen activators in the pathogenesis of delayed radiation damage in rat cervical spinal cord in vivo. Rad. Res. 138: 386-391, 1994.
40. SCHLEEF, R.R., and LOSKUTOFF, D.J. Fibrinolytic system of vascular endothelial cells. Haemostasis. 18: 328-341, 1988.
41. SHAY, J.W., WRIGHT, W.E., and WERBIN, H. Defining the molecular mechanisms of human cell immortalization. Biochim. Biophys. Acta. 1072: 1-7, 1991.
42. SHAY, J.W., WEST, M.D., and WRIGHT, W.E. Re-expression of Senescent Markers in De-induced Reversibly Immortalized Cells. Exp. Gerontology. 27: 477-492, 1992.
43. UCHIDA, N., TAKAHASHI, K., KASAI, T., ISHIDA, T., and KWAAN, H.C. The concomitant augmentation of urokinase-type plasminogen activator and collagenase-like proteinase activities in X-ray irradiated cells of a human metastatic carcinomatous line. Thromb. Res. 74: 565-576, 1994.
44. VAN MOURIK, J.A., LAWRENCE, D.A., and LOSKUTOFF, D.J. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. J. Biol. Chem. 259: 14914-14921, 1984.
45. WEST, M.D. The Cellular and Molecular Biology of Skin Aging. Arch. Dermatol. 139: 87-95, 1994.
46. WEST, M.D., PEREIRA-SMITH, O.M., and SMITH, J.R. Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp. Cell Res. 184: 138-147, 1989.
47. WEST, M. D., WRIGHT, W.E., and SHAY, J.W. Cellular senescence correlates with a constitutive overexpression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1. J. Cell Biol. 111: 270a, 1990.
48. WEST, M.D., WRIGHT, W.E., and SHAY, J.W. Transcriptional Mechanisms Regulating the Overexpression of Plasminogen Activator Inhibitor-1 in Senescent Fibroblasts. The Gerontologist 31: 314, 1991.
49. WIMAN, B., ALMQUIST, A., SIGURDARDOTTIR, O., and LINDAHL, T. Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma. FEBS Lett. 242: 125-128, 1988.
50. WIMAN, B., LJUNGBERG, B., CHMIELEWSKA, J. URDEN, G., BLOMBACK, M., and JOHNSON, H. The role of the fibrinolytic system in deep vein thrombosis. J. Lab. Clin. Med. 105: 265-270, 1985.